Recurrent Major Depression Clinical Trial
— WWSOfficial title:
Brain Mechanisms of Mindfulness Based Cognitive Therapy in Women at High Risk for Depressive Relapse ("The Women's Wellness Study")
NCT number | NCT04106375 |
Other study ID # | 13-0257 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 5, 2016 |
Est. completion date | February 19, 2018 |
Verified date | September 2019 |
Source | University of Colorado, Boulder |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of the study is to examine the efficacy of mindfulness based cognitive therapy (MBCT) on the prevention of relapse in women with a history of depression. Additionally, the investigators will explore how brain activity might be affected in several brain regions as a result of MBCT. This study consists of two groups, a patient group consisting of women with a history of depression and a control group consisting of healthy women. All participants within the patient group will receive an 8-week MBCT intervention program and will continue their normal medication treatment. Participants will undergo, both pre and post intervention, various behavioral and neuroimaging tasks to assess intervention effects of well-established psychological measurements related to cognitive and emotional function.
Status | Completed |
Enrollment | 50 |
Est. completion date | February 19, 2018 |
Est. primary completion date | February 19, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 55 Years |
Eligibility |
Inclusion Criteria: Inclusion Criteria: 1. Women with past history of recurrent major depressive disorder 1. Women who are not currently pregnant 2. Meeting criteria for prior depression (at least two episodes) and showing residual symptoms of depression (PHQ-9 score of 5-12) 3. Not meeting criteria for a current active depressive episode (SCID criteria) 4. Having access to internet and a smartphone with data plan 5. Receiving no antidepressant/anxiolytic medication or under a stable regime of antidepressants/anxiolytics 2. Healthy control women 1. Women that are not currently pregnant 2. Do not meet criteria for prior or current depression 3. Have access to internet and a smartphone with data plan Exclusion Criteria: Exclusion criteria for all participants include: - Current diagnoses of: psychosis, bipolar disorder/maniac episodes, OCD, persistent antisocial behavior, severe developmental delay, or persistent self-injury needing clinical management or therapy, organic brain injury, substance misuse. - Past diagnoses of psychosis, bipolar disorder/mania episodes or OCD. - Use of marijuana equal or more than 4 days per week. Additional exclusion criteria related to Magnetic Resonance Imaging safety requirements: We will exclude participants who have metal or electrical equipment including: - Non-removable metal piercing - Tattoos on head or neck, an older tattoo with metal-containing inks, and/or permanent makeup (eyeliner). - An implanted (internal) defibrillator or pacemaker - Cochlear (ear) implant - Some type of clips used on brain aneurysms - An intrauterine device (IUD) that is not compatible with the MRI scanner - An implanted infusion pump device like an insulin pump - Implanted nerve stimulators - Magnetic dental appliances or fillings - Metal plates, screws, staples, joint replacement, and prosthetics. Additional exclusion criteria for all participants include the following: - Clear claustrophobic symptoms. - Abnormal capability of performing the experimental tasks as they are designed and implemented (e.g., unable to read, unable to cooperate during fMRI examination, showing visual processing impairments that cannot be corrected using lenses or any significant impairments in the processing of auditory stimulation). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Boulder | Brain & Behavior Research Foundation, Children's Hospital Medical Center, Cincinnati, Mind and Life Institute, Hadley, Massachusetts, University of Arizona, University of Toronto |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Occurrence of mood episodes and post treatment relapse rate | Assessed via clinical interview | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Depression symptoms | Assessed via Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001) | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Rumination | Rumination score measured using the Ruminative Response Scale (RRS; Nolen-Hoeksema 1987;1999). | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Cognitive Decentering | Score in the Experiences Questionnaire (Fresco, Moore, Dulmen, Segal, Ma, Teasdale, & Williams, 2007) | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Self-Compassion | Self-compassion scores measured using the Self-Compassion Scale (SCS: Neff, 2003). | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Mindfulness | Score on the Five-factor Mindfulness Scale (FFMQ; Baer, Smith, Hopkins, Krietemeyer & Toney, 2006) | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Autobiographical Memory | Assessed via the Autobiographical Memory Test (Williams & Broadbent, 1986) | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Self concept | Assessed via the Twenty Statements Test (Kuhn and McPartland, 1954) | Throughout study (pre-intervention to 6 months post-intervention) | |
Primary | Brain activity during autobiographical memory recall | Measured using task-based fMRI bold sequence | Up to 15 weeks | |
Primary | Brain activity in the absence of a task | Measured using fMRI resting-state bold sequence | Up to 15 weeks | |
Primary | Brain activity during processing of self-referential traits | Measured using task-based fMRI bold sequence | Up to 15 weeks | |
Primary | Everyday thinking patterns | Measured with experience sampling in daily life, questions developed for our study | Up to 15 weeks | |
Secondary | Mindfulness | Assessed using the previously validated breath counting task (Levinson et al., 2014) | Up to 15 weeks | |
Secondary | Lexical Associations | Assessed using the Thought fluency task (Andrews-Hanna et al., in prep.) | Up to 15 weeks | |
Secondary | Worry | Worry score using the Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990). | Throughout study (pre-intervention to 6 months post-intervention) | |
Secondary | Fatigue | Assessed using the Multidimensional Fatigue Inventory (Smets et al. 1995). | Throughout study (pre-intervention to 6 months post-intervention) | |
Secondary | Physical pain | Assessed using the Brief Pain Inventory-short form (Cleeland and Ryan, 1994). | Throughout study (pre-intervention to 6 months post-intervention) | |
Secondary | Expectations about treatment outcome | Score in the Credibility/Expectancy Questionnaire (CEQ, Devilly, G. J., & Borkovec, T. D. 2000) | Pre-intervention | |
Secondary | Client satisfaction about treatment outcome | Assessed using the Client Satisfaction Questionnaire (CSQ, Attkisson & Greenfield, 2009). | Up to 15 weeks | |
Secondary | Positive and negative emotion | Assessed by measuring responses while watching emotional movies (based on Gruber et al, 2008) | Up to 15 weeks | |
Secondary | Positive and negative affect | Assessed using the Positive and Negative Affect Scale (PANAS; Watson & Clark, 1994) | Throughout study (pre-intervention to 6 months post-intervention) | |
Secondary | Emotion-induced attentional bias | Assessed using the dot-brobe task (Kruijt et al., 2016) | Up to 15 weeks | |
Secondary | Mind wandering | Score on the Imaginal Process Inventory (IPI, Singer et al., 1963) | Throughout study (pre-intervention to 6 months post-intervention) | |
Secondary | Well-being | Assessed via the Ryff Scales of Psychological Well-Being (RYFF; Ryff, 1989; Ryff & Keyes, 1995) | Throughout study (pre-intervention to 6 months post-intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05221567 -
Intensive Psychotherapy for Chronic Depression
|
N/A |